General Hospital Psychiatry
Volume 27, Issue 2 , Pages 150-152 , March 2005

A “shrinking” patient — an endocrine disorder?

  • Axel Ropohl, M.D.

      Affiliations

    • Current address: Zentrum für integrative Psychiatrie GmbH, Niemannsweg 147, 24105 Kiel, Germany.

Received 9 August 2004 ,Accepted 11 November 2004.

References 

  1. Perugi G, Akiskal HS, Giannotti D, et al. Gender-related differences in body dysmorphic disorder (dysmorphophobia). J. Nerv. Ment. Dis. 1997;185:578–582
  2. Cororve MB, Gleaves DH. Body dysmorphic disorder: a review of conceptualizations, assessment, and treatment strategies. Clin. Psychol. Rev. 2001;21:949–970
  3. Sarwer DB, Wadden TA, Pertschuk MJ, et al. Body image dissatisfaction and body dysmorphic disorder in 100 cosmetic surgery patients. Plast. Reconstr. Surg. 1998;101:1644–1649
  4. Kovacs K, Horvath E. Pathology of pituitary tumors. Endocrinol. Metab. Clin. North Am. 1987;16:529–551
  5. Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. J. Clin. Endocrinol. Metab. 1998;83:379–381
  6. Phillips KA. Pharmacologic treatment of body dysmorphic disorder. Psychopharmacol. Bull. 1996;32:597–605
  7. Neziroglu F, Khemlani-Patel S. A review of cognitive and behavioral treatment of body dysmorphic disorder. CNS Spectr. 2002;7:464–471
  8. Glassman AH, Bigger JT. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry. 2001;158:1774–1782
  9. Phillips KA. Quality of life for patients with body dysmorphic disorder. J. Nerv. Ment. Dis. 2000;188:170–175
  10. Altamura C, Paluello MM, Mundo E, et al. Clinical and subclinical body dysmorphic disorder. Eur. Arch. Psychiatry Clin. Neurosci. 2001;251:105–108

PII: S0163-8343(04)00139-2

doi: 10.1016/j.genhosppsych.2004.11.003

General Hospital Psychiatry
Volume 27, Issue 2 , Pages 150-152 , March 2005